Concepedia

Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial

Paul E. Goss, Dawn L. Hershman, Angela M. Cheung, James N. Ingle, Sundeep Khosla, Vered Stearns, Haji Chalchal, Kendrith M. Rowland, Hyman B. Muss, Hannah M. Linden,

The Lancet Oncology · 2014 · 53 citations · 28 references

References

28

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff et al. · Osteoporosis International · 2014 · 4.1K citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +16

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

S. R. Cummings · JAMA · 1998 · 2.3K citations

Medicine, Endocrinology, Bone Augmentation +16

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Pharmacy, Endocrinology, Oncology +13

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

Cancer · 2003 · 858 citations

Medicine, Oncology, Breast Oncology +15